Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of GW 786034 (Pazopanib) in Advanced Thyroid Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00625846
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:48.254635+00:00
Published At
2020-02-26T00:00:00+00:00
Record Updated At
2020-02-26
Results Posted At
2020-02-26
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Recurrent Thyroid Gland Carcinoma", "Stage III Differentiated Thyroid Gland Carcinoma AJCC v7", "Stage III Thyroid Gland Medullary Carcinoma AJCC v7", "Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7", "Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7", "Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7", "Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7", "Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7", "Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7", "Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7", "Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7", "Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7", "Thyroid Gland Anaplastic Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-02-26"
protocolSection.identificationModule.nctId
"NCT00625846"
protocolSection.identificationModule.officialTitle
"A Phase II Study of GW 786034 (Pazopanib) in Advanced Thyroid Cancer"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-02-26"

Study condition terms

  • Recurrent Thyroid Gland Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Differentiated Thyroid Gland Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Thyroid Gland Medullary Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Thyroid Gland Anaplastic Carcinoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.